Enjoy complimentary customisation on priority with our Enterprise License!
The global eClinical solutions market size is estimated to grow by USD 9.65 billion at a CAGR of 13.47% between 2022 and 2027.
A clinical trial management system (CTMS) enables effective communication and collaboration between the different stakeholders involved in the trial. CTMS provides a centralized and secure platform for storing and managing sensitive clinical trial data. This ensures data integrity, reduces the risk of data errors, improves data security, and protects both patient information and research results.
Study Period | 2023-2027 |
Base Year For Estimation |
2022 |
CAGR | 13.47% |
Forecast period |
2023-2027 |
Fastest Growing Region |
North America at 41% |
Largest Segment |
End-User |
CTMS automates many manual processes, reducing administrative burden and improving operational efficiency. This not only saves time but also reduces operating costs associated with running clinical trials, which can positively impact the market's growth during the forecast period. This market research and analysis report also includes an in-depth analysis of drivers, trends, and challenges. Our market analysis and report examines historic data from 2017 to 2021, besides analyzing the current market scenario.
The market is propelled by technological advancements and the increasing demand for efficient clinical trial management systems (CTMS). These solutions streamline data management, randomization, and trial supply management, ensuring compliant submissions and authenticating data integrity. With a focus on personalized medicines and healthcare essentials, eClinical solutions reduce drug development time and enhance decision-making processes. Despite initial capital investment and maintenance costs, the market addresses emerging markets' needs, backed by government emphasis on healthcare and operational data management for improved clinical research outcomes.
In the market, end-users such as healthcare staff and life sciences organizations play a crucial role in leveraging software solutions to manage vast data scales efficiently. With government emphasis on healthcare essentials and stringent regulatory structures, there's a growing demand for eClinical solutions to streamline clinical trial processes. Contract research organizations (CROs) and skilled professionals rely on these solutions for patient recruitment, ensuring eConsent compliance, and enhancing patient compliance throughout the clinical trial enrollment process. These solutions facilitate seamless collaboration between stakeholders, optimize data management, and improve overall efficiency in clinical trial operations. As a result, eClinical solutions have become indispensable tools in modern clinical research, empowering organizations to conduct trials effectively and expedite the development of innovative healthcare solutions.
The market share growth by the Pharmaceutical and biotechnology companies segment will be significant during the forecast period. Pharmaceutical and biotechnology companies face many issues regarding the scrutiny of their clinical trials, which can result in a huge loss of time and money. The need for data management has led these companies to increasingly adopt eClinical solutions, such as CTMS. Market players have entered into longstanding partnerships with companies to enhance the clinical trial experience.
The Pharmaceutical and biotechnology companies segment was valued at USD 2.31 billion in 2017. eClinical solutions offer many benefits, including easy access to real-time testing information, making faster, well-informed decisions, lower trial fees, lower R&D costs, and increase employee productivity and job satisfaction. Thus, an increase in the number of diseases has led to an increase in the number of clinical trials. These trials focus on introducing advanced drugs for effective treatment. Currently, many drugs from the major pharmaceutical and biotech companies are in the clinical development/preparation phase. Therefore, with the increase in clinical trials, the need to administer them to improve business operations is increasing, thus increasing the demand.
North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. the easy regulatory process, a large number of pharmaceutical and biotech companies as well as CRO in the region, and large investments in clinical trial research are the main factors driving the growth of the company. market. The main contributors to revenue in North America are the US, followed by Canada and Mexico. The growing prevalence of chronic diseases in the region has led to an increase in health spending. The national healthcare budget in the US is projected to grow at an average annual rate of 5.4% from 2019 to 2028 and reach USD 6.2 trillion by 2028. Hence, such factors are expected to drive the growth of the CTMS market in North America during the forecast period.
Buy Now Full Report and Discover More
The market is witnessing significant growth driven by advancements in data management and technological innovation. These solutions streamline clinical trial management systems, including randomization and trial supply management, ensuring compliance and authentication of data integrity. With a focus on personalized medicines and emerging markets, life sciences organizations benefit from efficient decision-making processes and reduced drug development time. Despite initial capital investment and maintenance costs, eClinical solutions enhance operational data management and enable compliant submissions. They also address challenges such as patient recruitment backlog and ensure patient compliance through innovative eConsent methods. Skilled professionals and government emphasis further drive adoption, shaping the regulatory structure for improved healthcare essentials delivery. There are multiple factors influencing market growth analysis. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
Rise in clinical trials for drugs is driving the growth of the market. The availability of a skilled workforce, favorable market reforms, access to the world's fastest-growing pharmaceutical market, strong intellectual property, and improved clinical trial infrastructure have contributed to an increase in the number of clinical trials in developing countries. This will increase the use of eClinical solutions at different stages of drug development. Millions of compounds are reviewed and evaluated in the R&D process, only a few of which will eventually receive approval.
Moreover, the overall probability of clinical success, that is, the chance of a drug being approved, is estimated to be less than 12%. As a result, companies with ongoing clinical trials need eClinical solutions to manage data loads generated during different phases of clinical trials. As a result, the growing number of clinical trials has led to an increase in demand for them worldwide. Hence, the increasing number of clinical trials for the drug will fuel the growth of the global market during the forecast period.
High adoption of cloud computing is the primary trend in the market. Cloud adoption brings many benefits to eClinical solutions, involving the use of technology to streamline and improve clinical research processes. Cloud computing allows it to scale up or down resources as needed. Cloud computing reduces the need for large investments in hardware and infrastructure. Organizations can pay for cloud services based on usage, making it a more cost-effective option, especially for small research institutes or startups.
Moreover, eClinical's cloud-based solutions can easily integrate with other cloud services and third-party applications, such as EHRs, lab systems, or wearables, facilitating exchange data exchange and interoperability. Cloud adoption can accelerate this by improving accessibility, scalability, cost-effectiveness, data management, analytic capabilities, and security, which is expected to fuel the growth of the market during the forecast period.
Cost and resource constraints of eClinical solutions are the challenge that affects the growth of the market. They often involve significant upfront costs, including licensing, deployment, and hardware infrastructure. Small organizations with limited budgets can find it difficult to make these initial investments. Cloud-based eClinical solutions are typically priced on a subscription basis, which can be an ongoing cost for organizations.
Moreover, depending on the size of use and the functionality required, subscription fees can become burdensome for smaller organizations. Cost constraints can slow the adoption of such solutions among healthcare providers and research institutions. This slow adoption could result in missed opportunities to improve clinical trial efficiency, data quality, and patient engagement. As a result, cost constraints may impede the growth of the market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Veeva Systems Inc.: The company offers eClinical solution such as Veeva Vault CTMS which provides end-to-end study management and monitoring capabilities for insourced and outsourced trials.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The global market is at the forefront of revolutionizing clinical research outcomes through advancements in technology and data management. From randomization and trial supply management to authentication of data integrity and reliability, these solutions ensure compliant submissions and streamline the decision-making process. By optimizing operational data management and leveraging technological advancements, companies aim to reduce drug development time and improve patient recruitment. The market also addresses emerging needs such as personalized medicines, considering factors like initial capital investment and maintenance cost. With a focus on healthcare essentials and government emphasis on regulatory structure, eClinical solutions play a crucial role in enhancing patient compliance and advancing clinical trial processes worldwide.
In the realm of healthcare, the market stands out as a beacon of innovation and efficiency. With technological advancement driving progress, this market caters to the needs of both an established and emerging market, offering tailored solutions to address diverse challenges. Amid reimbursement circumstances and backlog, eClinical solutions streamline processes, ensuring optimal utilization of healthcare staff and managing Vast data scale. These software solutions are instrumental in enhancing operations for contract research organizations (CROs) and life sciences organizations, facilitating tasks like eConsent and clinical trial enrollment. To maintain high standards, the market relies on skilled professionals to implement and optimize these solutions effectively.
The market serves as a vital cornerstone, offering a comprehensive suite of tools to enhance research and patient care. From contact management sites and teams to calendar and monitoring functionalities, these solutions streamline operations, ensuring seamless collaboration and efficient scheduling. Robust document management capabilities facilitate secure storage and regulation of data, while advanced systems regulate data entry processes. By providing insights into patient experiences and disease load, eClinical solutions enhance data visibility and mitigate data fragmentation. Through automation and integration with multiple applications, these solutions optimize research infrastructure, empowering organizations to drive innovation and improve healthcare outcomes globally.
This market research and growth report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
eClinical Solutions Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 13.47% |
Market growth 2023-2027 |
USD 9.65 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
12.7 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 41% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Vendors, Market Growth and Trends, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Advarra Inc., Aixial, Anju Software Inc., ArisGlobal LLC, Castor Research Inc., Dassault Systemes SE, DATATRAK International Inc., eClinical-Solutions LLC., eClinicalWorks LLC, eResearchTechnology GmbH, International Business Machines Corp., MedNet, Medrio Inc., OpenClinica LLC, Oracle Corp., Parexel International Corp., Saama Technologies Inc., Signant Health, Veeva Systems Inc., and YPrime LLC |
Market dynamics |
Market trends and analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Deployment
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.